TP53 and neoplasm: A cancer genome profiling (FoundationOne CDx) of the primary tumor (Figure 4) revealed pathogenic gene mutations in MSH6, PIK3CA, PTEN, 1and TP53 and pathogenic gene amplification of CCNE1. The tumor was MS-stable and TMB-high (14.5/Mb).